XORTX to Present at BIO International Convention 2024
Provided By GlobeNewswire
Last update: Jun 4, 2024
CALGARY, June 04, 2024 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat progressive kidney disease, is pleased to announce its participation in the BIO International Convention 2024, being held June 3rd through 6th, 2024. Dr. Allen Davidoff, XORTX’s CEO, will present an overview on the Company, including the Company’s progress to date and planned future regulatory and clinical activities.
Read more at globenewswire.comNASDAQ:XRTX (10/14/2025, 8:00:03 PM)
0.8748
0 (-0.39%)
Find more stocks in the Stock Screener
